Literature DB >> 24243902

CELL BIOLOGY SYMPOSIUM: Impacts of maternal obesity on placental and gut inflammation and health.

M J Zhu1, M Du, S P Ford.   

Abstract

Obesity in pregnant women is a growing public health concern that negatively affects fetal development and has long-term impacts on offspring health. The placenta plays an essential role in nutrient transport to the fetus and supports fetal growth and development. Maternal obesity (MO) induces an exacerbated proinflammatory milieu in the placenta providing an inflammatory environment for fetuses. The gut is one of the largest immune organs and mainly develops during the fetal stage. Maternal obesity and the corresponding inflammatory uteroplacental environment affect gut development, incurring inflammatory responses in the fetal intestine that further prime or program the offspring gut to enhance inflammation and impair intestinal barrier integrity. This review summarizes the impact of MO on inflammatory responses in placenta and fetal intestine and the long-term effects on offspring intestinal health. Because "leaky gut" is one of the main etiological factors for a number of common diseases, including inflammatory bowel diseases, type I diabetes, and related autoimmune diseases, the adverse effect of MO on the overall health of progeny is further discussed.

Entities:  

Mesh:

Year:  2013        PMID: 24243902     DOI: 10.2527/jas.2013-7106

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  3 in total

1.  Oxidative stress biomarkers and their relationship with cytokine concentrations in overweight/obese pregnant women and their neonates.

Authors:  María Hernández-Trejo; Araceli Montoya-Estrada; Yessica Torres-Ramos; Aurora Espejel-Núñez; Alberto Guzmán-Grenfell; Rosa Morales-Hernández; Maricruz Tolentino-Dolores; Estibalitz Laresgoiti-Servitje
Journal:  BMC Immunol       Date:  2017-01-07       Impact factor: 3.615

2.  Maternal cardiometabolic markers are associated with fetal growth: a secondary exploratory analysis of the LIMIT randomised trial.

Authors:  Cecelia M O'Brien; Jennie Louise; Andrea Deussen; Jodie M Dodd
Journal:  BMC Endocr Disord       Date:  2019-10-10       Impact factor: 2.763

3.  Early life exposure to maternal insulin resistance has persistent effects on hepatic NAFLD in juvenile nonhuman primates.

Authors:  Stephanie R Thorn; Karalee C Baquero; Sean A Newsom; Karim C El Kasmi; Bryan C Bergman; Gerald I Shulman; Kevin L Grove; Jacob E Friedman
Journal:  Diabetes       Date:  2014-04-04       Impact factor: 9.461

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.